Nucleic acids encoding factor X deletion mutants and analogues thereof

US6905846B2 · kind B2 · utility

Assignee

• Baxter Aktiengesellschaft · AT

Inventors

• Michele Himmelspach · Port, CH
• Michael Pfleiderer · Darmstadt, DE
• Falko-Guenter Falkner · Orth an der Donau, AT
• Johann Eibl · Wien, AT
• Friedrich Dorner · Wien, AT
• Uwe Schlokat · Orth an der Donau, AT

Key dates

• Filing date: Jan 21, 2003
• Grant date: Jun 14, 2005
• Expiry date: Oct 10, 2023

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K38/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Nucleic acids encoding factor XΔ analogues having a deletion of amino acids Arg180 to Arg234 and a modification in the region of the amino acid sequence between Gly173 and Arg 179 are provided.